Luven Diagnostic
(LVD)

The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages , thus, giving a chance to thousands of people to prevent its further development.

Yana Ivchenko

Token info

Investment info

1983 - Development started

Development of the cancer diagnostic method started, based on the study of buccal cells(cells from the inside of the cheek).

2

2004 - Formation of the methodology

A cytomorphobiologial diagnostic method appeared which formed the basis of the diagnostic complex.

3

2010 - Team expansion

Team expansion. A commercial enterprise promoting the LUVEN trademark was established. The software automating a part of the diagnostic procedure was created.

4

2014 - Patents

The diagnostic method was patented, completion of the clinical trials, creation of the software diagnostic complex presented at two international medical exhibitions “The 5th International Medical Forum” and “Health Care 2014”. Opening first franchise outlets.

5

2015 - Franchise

In five months after launching a franchise, the contracts were signed with more than twenty outlets, half of which have already run tests on more than two thousand patients. Suspension of activities for a time allowing technology enhancement.

6

2016 - 2017 - Software enhancement

Software enhancement, additional clinical trials. Optimizing a big number of the system algorithms.

7

September - December 2017 - Preparing and starting a preICO

Preparing and starting a preICO aimed at fundraising for the software enhancement, legal costs and operational expenses of the project.

PREICOStart: 12.12.2017 12:00 GMT Finish: 29.12.2017 12:00 GMT

8

January 2018 - Starting an ICO

ICOStart: 15.01.2018 12:00 GMT Finish: 28.02.2018 12:00 GMT

9

2018 - Further software enhancement

Further software enhancement, signing contracts with clinics worldwide for conducting clinical trials, opening a research center in Austria. Initiating certification of the method in the European Union and Eurasian Union.

10

2019 - European Union and Eurasian Union

Opening 20 new labs in the European Union and Eurasian Union, incorporating a blockchain and developing a domestic exchange for token sale, working on the optical recognition of incoming images of the cell, creating a database of patients and their test results for monitoring tendencies and informing patients on the necessity of being diagnosed.

11

2020 - USA and Asia

Starting clinical trials and certification in the USA and Asia.

12

2021 - Developing home gadgets

Developing home gadgets (a home lab) for running tests on the entire family at any time, launching the product.

TrackICO does not encourage investing in any ICOs published on the platform. Make sure
to do
your own thorough research before putting money into Initial Coin Offerings. All content
on
TrackICO is meant to be used for information purposes only, and should not be taken as
financial
or investment advice.

About

TrackICO - a platform that was established to provide
its
users
reliable information about the best Initial Coin Offering projects and help ICOs attract
more
investors.